Context Therapeutics Inc. (NASDAQ:CNTX – Get Free Report) was the target of a significant increase in short interest in March. As of March 15th, there was short interest totalling 17,000 shares, an increase of 57.4% from the February 29th total of 10,800 shares. Currently, 0.1% of the company’s shares are short sold. Based on an […]